|
|
||||||||
1Department of Medicine, Renal Division, Brigham and Women's Hospital, Boston, Massachusetts; 2Department of Medicine, Renal Unit, Massachusetts General Hospital, Boston, Massachusetts; 3Department of Anatomy, School of Medicine, Kyungpook National University, Daegu, Korea; 4Department of Molecular Biology and Microbiology, Biomolecular Science Center, University of Central Florida, Orlando, Florida; and 5Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology, Cambridge, Massachusetts
Submitted 20 October 2004 ; accepted in final form 22 December 2004
Acute renal failure (ARF) is characterized by a very high mortality essentially unchanged over the past 40 years. Simple vertebrate models are needed to improve our understanding of ARF and facilitate the development of novel therapies for this clinical syndrome. Here, we demonstrate that gentamicin, a commonly used nephrotoxic antibiotic, causes larval zebrafish to develop ARF characterized by histological and functional changes that mirror aminoglycoside toxicity in higher vertebrates and inability of zebrafish to maintain fluid homeostasis. We developed a novel method to quantitate renal function in larval zebrafish and demonstrate a decline in glomerular filtration rate after gentamicin exposure. The antineoplastic drug cisplatin, whose use in humans is limited by kidney toxicity, also causes typical histological changes and a decline in renal function in larval zebrafish. A specific inhibitor of Omi/HtrA2, a serine protease implicated in cisplatin-induced apoptosis, prevented renal failure and increased survival. This protective effect was confirmed in a mouse model of cisplatin-induced nephrotoxicity. Therefore, zebrafish provides a unique model system, amenable to genetic manipulation and drug screening, to explore the pathophysiology of ARF and establish novel therapies with potential use in mammals.
animal model; drug development; glomerular filtration; fluorescence
This article has been cited by other articles:
![]() |
B. Daroczi, G. Kari, Q. Ren, A. P. Dicker, and U. Rodeck Nuclear factor {kappa}B inhibitors alleviate and the proteasome inhibitor PS-341 exacerbates radiation toxicity in zebrafish embryos Mol. Cancer Ther., September 1, 2009; 8(9): 2625 - 2634. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Hentschel, M. Mengel, L. Boehme, F. Liebsch, C. Albertin, J. V. Bonventre, H. Haller, and M. Schiffer Rapid screening of glomerular slit diaphragm integrity in larval zebrafish Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1746 - F1750. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Daroczi, G. Kari, M. F. McAleer, J. C. Wolf, U. Rodeck, and A. P. Dicker In vivo Radioprotection by the Fullerene Nanoparticle DF-1 as Assessed in a Zebrafish Model Clin. Cancer Res., December 1, 2006; 12(23): 7086 - 7091. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bahary Tales from the deep: reeling in renal failure Am J Physiol Renal Physiol, May 1, 2005; 288(5): F921 - F922. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |